Technology Services. Services including, but not limited to, ongoing and new benchtop research activities related to cancer biomarker assays within the field of use of the licensed technologies, laboratory assay development and enhancement, improvements in laboratory assay performance, cost, and efficiency.
Appears in 4 contracts
Sources: Consulting Agreement (Lucid Diagnostics Inc.), Consulting Agreement (Lucid Diagnostics Inc.), Consulting Agreement (Lucid Diagnostics Inc.)